Illumina ILMN
NASDAQ ILMN
$245.18 +16.25 (+7.10%)
At close: Sep 17, 2026 · 4:00 PM EDT

Illumina (ILMN) Total Non-Current Liabilities (2010 - 2026)

Illumina's (ILMN) quarterly Total Non-Current Liabilities came in at $3.5 billion in Q2 2026, up 1.21% on a YoY basis from $3.5 billion in Q2 2025, and little changed quarter-over-quarter from $3.5 billion in Q1 2026.

Analysis

Illumina (ILMN) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Illumina (ILMN) has reported Total Non-Current Liabilities for 17 consecutive years, with $3.5 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Non-Current Liabilities rose 1.21% year-over-year to $3.5 billion; the trailing twelve-month figure through Jun 2026 stood at $3.5 billion (up 1.21% YoY), and the FY2025 full-year result was $3.6 billion, down 0.84% from the prior year.
  • Total Non-Current Liabilities was little changed at $3.5 billion in Q2 2026 per ILMN's latest filing, from $3.5 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $5.0 billion in Q1 2023 and bottomed at $3.5 billion in Q3 2025.
  • Historically, Total Non-Current Liabilities has averaged $3.8 billion across 5 years, with a median of $3.6 billion in 2024.
  • The widest YoY moves for Total Non-Current Liabilities: up 40.48% in 2023, down 25.14% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $3.9 billion in 2022, then dropped by 4.24% to $3.7 billion in 2023, then slipped by 4.14% to $3.6 billion in 2024, then retreated by 0.84% to $3.6 billion in 2025, then slipped by 1.07% to $3.5 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $3.5 billion, $3.5 billion, and $3.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 55.95 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 33.25 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 6.06 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 3.52 Bn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 4.05 Bn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 457.16 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 2.88 Bn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 821.06 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 197.96 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 3.06 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 3.52 Bn
Mar 29, 2026 3.53 Bn
Dec 28, 2025 3.56 Bn
Sep 28, 2025 3.46 Bn
Jun 29, 2025 3.48 Bn
Mar 30, 2025 3.47 Bn
Dec 29, 2024 3.59 Bn
Sep 29, 2024 3.58 Bn
Jun 30, 2024 4.31 Bn
Mar 31, 2024 3.66 Bn
Dec 31, 2023 3.75 Bn
Oct 1, 2023 3.67 Bn
Jul 2, 2023 4.52 Bn
Apr 2, 2023 4.46 Bn
Jan 1, 2023 5.00 Bn
Oct 2, 2022 3.91 Bn
Jul 3, 2022 4.15 Bn
Apr 3, 2022 3.53 Bn
Jan 2, 2022 3.56 Bn
Oct 3, 2021 3.39 Bn